These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3301161

  • 41. Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes.
    Sando H, Lee YS, Iwamoto Y, Ikeuchi M, Kosaka K.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1143-9. PubMed ID: 6999008
    [Abstract] [Full Text] [Related]

  • 42. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.
    Elkeles RS, Heding LG, Paisey RB.
    Diabetes Care; 1982 Nov; 5(4):427-9. PubMed ID: 6759080
    [Abstract] [Full Text] [Related]

  • 43. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
    Kruszynska YT, Ghatei MA, Bloom SR, McIntyre N.
    Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
    [Abstract] [Full Text] [Related]

  • 44. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects.
    Meistas MT, Rendell M, Margolis S, Kowarski AA.
    Diabetes; 1982 May; 31(5 Pt 1):449-53. PubMed ID: 6759260
    [Abstract] [Full Text] [Related]

  • 45. Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes.
    Thompson RG, Gottlieb A, Organ K, Koda J, Kisicki J, Kolterman OG.
    Diabet Med; 1997 Jul; 14(7):547-55. PubMed ID: 9223392
    [Abstract] [Full Text] [Related]

  • 46. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM, Hartog M, Goldie DJ, Alberti KG, Binder C, Faber OK.
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [Abstract] [Full Text] [Related]

  • 47. Arginine induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus.
    Cheng HM, Jap TS, Lee KT, Kwok CF, Ho LT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Sep; 50(3):184-8. PubMed ID: 1330242
    [Abstract] [Full Text] [Related]

  • 48. Reduced insulin secretion in normoglycaemic patients with beta-thalassaemia major.
    Angelopoulos NG, Zervas A, Livadas S, Adamopoulos I, Giannopoulos D, Goula A, Tolis G.
    Diabet Med; 2006 Dec; 23(12):1327-31. PubMed ID: 17116183
    [Abstract] [Full Text] [Related]

  • 49. Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus.
    Wolffenbuttel BH, Weber RF, Van Koetsveld PM, Verschoor L.
    Int J Obes; 1989 Dec; 13(2):173-82. PubMed ID: 2744929
    [Abstract] [Full Text] [Related]

  • 50. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J, Rönnemaa T, Koskinen P.
    Ann Clin Res; 1987 Dec; 19(3):178-82. PubMed ID: 3314647
    [Abstract] [Full Text] [Related]

  • 51. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ, van der Wal PS, Sweep CG, Smits P, Tack CJ.
    Diabetes Metab Res Rev; 2004 Dec; 20(6):466-71. PubMed ID: 15386823
    [Abstract] [Full Text] [Related]

  • 52. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 53. Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
    An Z, Prigeon RL, D'Alessio DA.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4702-8. PubMed ID: 24092826
    [Abstract] [Full Text] [Related]

  • 54. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level.
    Tasaka Y, Marumo K, Inoue Y, Hirata Y.
    Acta Endocrinol (Copenh); 1986 Nov; 113(3):355-62. PubMed ID: 3538738
    [Abstract] [Full Text] [Related]

  • 55. [Hypoglycemia-induced inhibition of insulin secretion in metabolically healthy subjects, in diabetics and in patients with adrenalectomy].
    Krause U, Faisst G, Cordes U, Beyer J.
    Verh Dtsch Ges Inn Med; 1986 Nov; 83():1391-3. PubMed ID: 611850
    [No Abstract] [Full Text] [Related]

  • 56. Insulin secretory response to oral glucose load, diabetic microangiopathy and diabetic control: a study in non-insulin dependent diabetics.
    Maneschi F, Cassar J, Lowy C, Kohner EM.
    Metabolism; 1982 Oct; 31(10):985-8. PubMed ID: 6752636
    [Abstract] [Full Text] [Related]

  • 57. Physical fitness, insulin secretion, and glucose tolerance in healthy males and mild type-2 diabetes.
    Lindgärde F, Malmquist J, Balke B.
    Acta Diabetol Lat; 1983 Oct; 20(1):33-40. PubMed ID: 6344526
    [Abstract] [Full Text] [Related]

  • 58. Insulin deficiency in non-insulin-dependent diabetics.
    Scott RS, Mason DR, Iris FJ, Bremer JR.
    Diabetes Res Clin Pract; 1986 Oct; 2(6):359-64. PubMed ID: 3545726
    [Abstract] [Full Text] [Related]

  • 59. Basal insulin secretion increases with the onset of non-insulin dependent diabetes.
    Garcia-Webb P, Bonser AM, Pelham J, Whiting D.
    Pathology; 1982 Jul; 14(3):323-5. PubMed ID: 6752834
    [Abstract] [Full Text] [Related]

  • 60. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M, Ross DA, Drew HM, Zarriello J.
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.